The Hsp70 co-chaperone CHIP has recently gained attention as a regulator of protein turnover. CHIP has now been reported to be a component of the ubiquitination cascade, specifically an E3 ligase. CHIP appears to be part of a system that diverts incorrectly folded proteins from chaperones to the proteasome.
Inside the crowded environment of a living cell there is a struggle over polypeptides exhibiting non-native conformations. Two alternative fates await these aggregation-prone species: either they are targeted for proteolysis by the cellular degradation machinery, or they are shielded from aggregation and fold to the native state with the help of molecular chaperones. Although we still know little about how the decision between these two fates is reached, degradation and refolding per se have been studied in considerable detail. In the case of targeted protein degradation, proteins exposing a degradation signal are marked for proteolysis by the 26 S proteasome by covalent attachment of the small protein ubiquitin [1] . Modification with ubiquitin chains requires a cascade of enzymes: a ubiquitin activating enzyme (E1), a ubiquitin conjugating enzyme (E2), a ubiquitin protein ligase (E3) and, for some substrates, a ubiquitin chain elongation factor (E4). Molecular chaperones of the Hsp70 family recognize stretches of hydrophobic amino acids that are aberrantly exposed on the surface of a protein. Together, these recent experiments indicate that CHIP plays a role in the negative regulation of chaperone-mediated protein folding and in the ubiquitination of non-native chaperone substrates. CHIP has thus emerged as a critical modulator of chaperone function with regard to the fate of substrate proteins. In contrast, the role(s) of Bag-1 in chaperone function is less clear. Although Bag-1 can, depending on its concentration, act as either a positive or negative modulator of Hsp70 refolding activity in vitro [10] , its precise function in vivo remains to be elucidated. Intriguingly, however, it appears that CHIP and Bag-1 both interact with molecular chaperones, their substrates, each other and the proteasome, leading to the attractive speculation that all these factors could be localized at the proteasome to form a 'super-complex' that may be optimized for efficient substrate protein degradation. There is indeed some precedent for such complexes, in that the 26 S proteasome was found to interact with various components of the cellular chaperone and degradation machineries, including ubiquitin ligases, Hsp70, Hsp90 and the p97/CDC48 AAA ATPase [18, 19] .
A number of important questions about the mechanism and physiological relevance of CHIP-and Bag-1-mediated substrate degradation remain to be addressed. With respect to Bag-1, at least two alternative mechanisms can be envisioned to account for its activity in protein degradation. Bag-1 might trigger the dissociation of Hsp70-substrate complexes at the proteasome and thereby enable the proteasomeassociated ubiquitination machinery to mark the substrates for degradation [5, 17] (Figure 2) . Alternatively, Bag-1 might inhibit binding of Hsp70 to non-native, already ubiquitinated substrates at the proteasome and thereby prevent futile refolding attempts by Hsp70. In addition, the lack of a UBL domain in several members of the Bag family [7] suggests that Bag proteins also regulate cellular Hsp70 activities that are independent of the proteasome.
With respect to CHIP, it has to be noted that the data demonstrating an E3-like ubiquitin ligase activity so far rely largely on in vitro experiments employing poorly defined substrates and on overexpression studies. But is CHIP both necessary and sufficient for the ubiquitination of physiological chaperone substrates at endogenous expression levels in vivo? The answer to this question probably has to await the establishment of stable cell lines allowing the tight control of CHIP expression levels. Alternatively, use of CHIP-depleted 
